4-bromomethylindanone | 67864-42-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 4-bromomethylindanone
• 英文别名: 4-Brommethyl-1-indanon；4-(Bromomethyl)indan-1-one；4-(bromomethyl)-2,3-dihydroinden-1-one
• CAS: 67864-42-0
• 化学式: C₁₀H₉BrO
• 分子量: 225.085
• InChiKey: RJHCIIVUUNMBQH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-bromomethylindanone 在 pyridinium hydrobromide perbromide 、 ammonium acetate 、 氢溴酸 、 potassium carbonate 、 溶剂黄146 作用下， 以 丙酮 、 xylene 为溶剂， 反应 8.25h， 生成 4-Oxo-9-phosphonomethyl-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine-2-carboxylic acid
  参考文献：
  名称：

  Bioisosteres of 9-Carboxymethyl-4-oxo-imidazo[1,2- a ]indeno[1,2- e ]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent In Vivo AMPA antagonists with longer durations of action

  摘要：

  A novel series of 2- and 9-disubstituted heterocyclic-fused 4-oxo-indeno[1,2-e]pyrazin derivatives was synthesized. One of them, the 9-(1 H-tetrazol-5-ylmethyl)-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazin-2-yl phosphonic acid 4i exhibited a strong and a selective binding affinity for the AMPA receptor (IC50 = 13 nM) and demonstrated potent antagonist activity (IC50 = 6 nM) at the ionotropic AMPA receptor. This compound also displayed good anticonvulsant properties against electrically-induced convulsions after ip and iv administration with ED50 values between 0.8 and 1 mg/kg. Furthermore, a strong increase in potency was observed when given iv 3 h before test (ED50 = 3.5 instead of 25.6 mg/kg for the corresponding 9-carboxymethyl-2-carboxylic acid analogue). These data confirmed that there is an advantage in replacing the classical carboxy substituents by their bioisosteres such as tetrazole or phosphonic acid groups. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00592-8

文献信息

• 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives,
  申请人：Rhone Poulenc Rorer S.A.

  公开号：US05990108A1

  公开（公告）日：1999-11-23

  Compounds of formula (I), wherein R is a hydrogen atom or a --COOH, -alk-COOH, --PO.sub.3 H.sub.2, --CH.sub.2 --PO.sub.3 H.sub.2, or --CH.dbd.CH--COOH radical, or a phenyl radical substituted by a carboxy radical, R.sub.1 is an alk-CN, -alk-COOH, -alk-Het, alk-PO.sub.3 H.sub.2 or -alk-CO--NH--SO.sub.2 R.sub.2 radical, R.sub.2 is an alkyl or phenyl radical, alk is an alkyl radical, Het is a saturated or unsaturated mono- or polycyclic heterocyclic ring containing 1-9 carbon atoms and one or more heteroatoms selected from O, S and N, said heterocyclic ring optionally being substituted by one or more alkyl, phenyl or phenylalkyl radicals, with the proviso that when R is a hydrogen atom or a --COOH or --PO.sub.3 H.sub.2 radical, R.sub.1 cannot be -alk-COOH, isomers, racemic mixtures, enantiomers and diastereoisomers thereof, salts thereof, the preparation thereof, intermediates thereof and drugs containing said compounds, are disclosed. The compounds of formula (I) have valuable pharmacological properties and are antagonists of the .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor also known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive antagonists of the N-methyl-D-aspartate (NMDA) receptor, and specifically ligands for NMDA receptor glycine modulator sites. ##STR1##

  公式（I）的化合物中，其中R是氢原子或--COOH，-alk-COOH，--PO.sub.3 H.sub.2，--CH.sub.2 --PO.sub.3 H.sub.2或--CH.dbd.CH--COOH基团，或被羧基基团取代的苯基基团，R.sub.1是alk-CN，-alk-COOH，-alk-Het，alk-PO.sub.3 H.sub.2或-alk-CO--NH--SO.sub.2 R.sub.2基团，R.sub.2是烷基或苯基基团，alk是烷基基团，Het是含有1-9个碳原子和一个或多个氧、硫和氮杂原子的饱和或不饱和的单环或多环杂环，所述杂环环可以被一个或多个烷基，苯基或苯基烷基基团取代，但当R是氢原子或--COOH或--PO.sub.3 H.sub.2基团时，R.sub.1不能是-alk-COOH，其异构体，外消旋混合物，对映异构体和二对映异构体，其盐，其制备方法，其中间体和含有所述化合物的药物。公式（I）的化合物具有有价值的药理作用，并且是α-氨基-3-羟基-5-甲基-4-异噁唑丙酸（AMPA）受体的拮抗剂，也称为谷氨酸受体。此外，公式（I）的化合物是N-甲基-D-天门冬氨酸（NMDA）受体的非竞争性拮抗剂，并且特异地是NMDA受体甘氨酸调节剂位点的配体。
• US06100264
  申请人：——

  公开号：——

  公开（公告）日：——
• DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE ANTAGONISTES DES RECEPTEURS AMPA ET NMDA, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CONTENANT
  申请人：Aventis Pharma S.A.

  公开号：EP0880522B1

  公开（公告）日：2001-09-19
• DERIVES DE 5H,10H-IMIDAZO(1,2-a)INDENO(1,2-e)PYRAZINE-4-ONE, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CO NTENANT
  申请人：RHONE-POULENC RORER S.A.

  公开号：EP0880522A1

  公开（公告）日：1998-12-02
• US5990108A
  申请人：——

  公开号：US5990108A

  公开（公告）日：1999-11-23